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Production of Shiga-Like Toxin by Escherichia coli 
Escherichia coli is one of several agents that cause intesti- 
nal disease in humans and animals. Four classes of E. coli 
have been recognized [1], Enterotoxigenic E. coli (ETEC) 
strains produce a heat-labile (LT) enterotoxin and/or a 
heat-stable (ST) enterotoxin. Enteroinvasive E. coli (EIEC) 
strains, like shigellae, penetrate and multiply within epi- 
thelial cells. Enteropathogenic E. coli (EPEC) strains be- 
long to certain serogroups that have been incriminated as 
pathogens by epidemiological studies. Some EPEC strains 
have been shown to adhere to cells of the intestinal mucosa 
and to produce pathognomonic lesions at the site of at- 
tachment. Enterohemorrhagic E. coli (EHEC) strains 
cause a distinct clinical syndrome (hemorrhagic colitis), 
and serotype 0157:H7 has been associated with this ill- 
ness. Neither EPEC nor EHEC strains produce classic en- 
terotoxins, nor are they enteroinvasive. 
Some strains of E. coli produce a cell-associated 
cytotoxin that is neutralized by antibodies against puri- 
fied Shiga toxin from Shigella dysenteriae type 1 [2-4]. 
The cytotoxins purified from one EPEC strain 026:H11 
(H30) and from one EHEC strain 0157:H7 (933) have bi- 
ologic activities (cytotoxicity for HeLa and Vero cells, 
lethality for mice, and enterotoxicity for ligated ileal seg- 
ments from rabbits) and subunit structures similar to those 
of Shiga toxin [5, 6]. The purpose of this study was to 
determine the frequency and levels of cytotoxin produc- 
tion for a wide variety of E. coli strains. Culture superna- 
tants and sonic lysates of 418 strains isolated from humans, 
animals, ajid food were examined for cytotoxic effects on 
HeLa cells and to see whether cytotoxicity could be neu- 
tralized by antibodies to Shiga toxin. 
Materials and Methods 
Bacterial strains. E. coli strains examined for pro- 
duction of Shiga-like toxin were obtained mainly from the 
Centers for Disease Control, Atlanta, Georgia. The 418 
strains were isolated over a period of 30 years from the 
following: humans with diarrhea, hemorrhagic colitis, 
hemolytic uremic syndrome, or no clinical manifestation 
of disease; calves with diarrhea; piglets with edema dis- 
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ease; or food. A total of 162 strains belonged to EPEC 
serogroups 026,044,055,086, Olll, 0119,0125,0126, 
0127, 0128, and 0142 [7] and were mainly outbreak iso- 
lates. Nine strains had been characterized as ETEC by Y-l 
adrenal cell assay (for LT) or infant mouse assay (for ST), 
and 10 strains were characterized as EIEC by the Sereny 
test. Nineteen strains belonged to serotype 0157:H7 and 
were EHEC. A total of 214 strains did not belong to EPEC 
serogroups, were not ETEC or EIEC, were not EHEC 
0157:H7, had no serological data available (strains iso- 
lated from healthy humans), or had not been assayed for 
enterotoxins and invasiveness. Four substrains of E. coli 
K12 (C600, 395-1, HB101, and K175) were also examined 
for production of Shiga-like toxin. Strains were stored at 
-70 C or lyophilized. 
Preparation of bacterial lysates. The strains were cul- 
tured in 500 ml of Chelex-treated syncase broth as previ- 
ously described [2]. The bacteria were harvested by cen- 
trifugation [2], and an aliquot of the culture supernatants 
was collected, filter-sterilized, and stored at -20 C. The 
bacterial cells were then washed twice in 0.85^o NaCl and 
resuspended in a volume of PBS (pH 7.4) equivalent to 
their wet weight. Samples (3 ml) of the bacterial suspen- 
sions were mixed with 2 ml of PBS and sonicated as pre- 
viously described [8]. The sonic lysates were clarified by 
centrifugation (8,000 g for 1 hr at 4 C), filter-sterilized, 
and stored at -20 C. The protein content of the bacterial 
lysates was estimated spectrophotometrically [9]. 
Cytotoxicity assays and toxin neutralization tests. Cy- 
totoxicity assays were performed with HeLa cells by the 
method of Gentry and Dalrymple [10]. Serial twofold di- 
lutions (1:2 to 1 
' 
.64) of culture supernatants or sonic ly- 
sates were tested, and the cytotoxic dose required to kill 
50^0 of HeLa cells (CD5o) was estimated by microscopic 
examination of the HeLa cells. If ^O^o of the HeLa cells 
were killed at a K64 dilution of a sample, 10-fold serial 
dilutions of this sample were tested. Cytotoxic titers were 
expressed as the reciprocal of the CDso/milliliter of cul- 
ture supernatant or sonic lysate and as per milligram of 
sonic lysate protein. 
Initially, neutralization assays were done on sonic ly- 
sates that had been previously frozen and thawed. How- 
ever, this procedure eliminated the low-level activity of 
some lysates. When this problem became apparent, neu- 
tralization assays were accomplished at the same time as 
the cytotoxicity assays by mixing serial dilutions of the 
lysates with a final 1:100 dilution of rabbit antibody to 
Shiga toxin or preimmune rabbit serum. The remaining 
steps were performed as described [2]. Neutralization as- 
says were also done on 10-fold serial dilutions of cytotoxic 
culture supernatants. The neutralizing titer of the rabbit 
antibody to Shiga toxin for 10 CD50 of S. dysenteriae 1 
strain 60R and E. coli strain H30 preparations was 1:1,600. 
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Results 
Levels ofcytotoxin produced by E. coli. By compar- 
ing the cytotoxic titers of lysates expressed as CDso/ml and 
CDso/mg of protein, we found that more reproducible 
results were obtained for some strains with the CDso/ml 
parameter. Therefore, the results were based on CDso/ml 
of sonic lysate, and the detectable levels of cell-associated 
cytotoxin were defined as follows: low (2 x 10^6 x 102 
CDs0), moderate (lOMO4 CDso), or high (lOMO8 CD5o). 
Nontoxic strains and low-level cytotoxin producers. As 
shown in table 1, 107 strains (26^0) had no detectable ac- 
tivity, and 262 strains (6397o) had low levels of cytotoxin 
in the sonic lysates. Culture supernatants of nontoxic 
strains and low-level cytotoxin producers had no detect- 
able activity. Low-level cytotoxin producers isolated from 
humans with hemorrhagic colitis belonged to serotypes 
06:H1, 017:H1, 075:H1, 083:H1, OllLNM, O nontypa- 
ble (NT):NM, and O NT:H NT. Strains isolated from 
piglets belonged to serogroups 0139 and 0141. 
Sonic lysates from only 125 of the 262 low-level cytotoxin 
producers retained HeLa cell activity in the neutralization 
assays, and 50 had this activity neutralized by antibody 
to Shiga toxin, including the following: lysates from 18 
strains belonging to EPEC serogroups isolated from hu- 
mans with diarrhea, three ETEC strains, five EI EC strains, 
six other strains isolated from humans with diarrhea, three 
strains isolated from humans with hemorrhagic colitis 
(serotypes 083:H1, OllLNM, O NT:H NT), 12 strains iso- 
lated from healthy humans, and three substrains oiE. coli 
K12. 
Nine strains that were isolated from healthy individu- 
als and that had either no detectable activity or low levels 
of a nonneutralizable cytotoxin in sonic lysates were 
retested by the French pressure method of lysis [2]. Al- 
though quite cumbersome, this method of bacterial lysis 
was more efficient than sonication: 95^0 of bacterial cells 
were killed by the French pressure method, whereas only 
70970 of cells were killed by sonication. All nine strains 
showed cytotoxic activity in the French pressure lysates, 
and one strain did not have this activity neutralized by an- 
tibody to Shiga toxin. In general, cytotoxic titers were 
slightly higher in French pressure lysates than in sonic ly- 
sates. 
Moderate-level cytotoxin producers. A total of 10 
strains (2^0), isolated from humans or calves with disease, 
produced moderate levels of a cell-associated cytotoxin (ta- 
bles 1 and 2). All strains had equal or 10-fold less CDso/ml 
of culture supernatant than per ml of sonic lysate. Cyto- 
toxic activity in sonic lysates and culture supernatants of 
these strains was not neutralized by antibody to Shiga 
toxin. The strains isolated from calves had been previously 
reported as producers of a cytotoxin neutralized by anti- 
body to Shiga toxin [11]. 
High-level cytotoxin producers. A total of 39 strains 
(9^0) produced high levels of cell-associated cytotoxin, and 
Table 1. Production of cell-associated cytotoxin by E. coli. 
No. of strains that made 
Source Clinical manifestation No detectable Low Moderate High 
of strain of disease Group cytotoxin levels levels levels 
Humans Diarrhea EPEC 57 89 0 6 
ETEC 0 9 0 0 
EIEC 0 9 0 0 
Others 30 35 1 1 
HC* EPEC 0 10 1 
EHEC 0 o 4 14 
Others 0 6 0 1 
HUSt EPEC 0 0 0 3 
Others 0 0 2 2 
None Others 3 44 0 1 
Calves Diarrhea EPEC 0 0 0 5 
Others 0 0 3 4 
Piglets Edema disease Others 17 64 0 0 
Food - EHEC 0 0 0 1 
EIEC 0 10 0 
Laboratory (K12) - - 0 4 0 0 
Total 107 262 10 39 
NOTE. Strains of E. coli were disrupted by sonic lysis, cytotoxic activity of bacterial lysates was detected on HeLa cells, and 
levels of cytotoxin production were defined by the CD5oZml of sonic lysate. 
* HC ^ hemorrhagic olitis. 
t HUS = hemolytic uremic syndrome. 





Diarrhea 0157:H7 (1) 04:NM (1) 
08:H9 (1) 
0149:H8 (1) 
HC* 0157:H7 (4) 
HUSt 0113:H21 (2) 
Diarrhea 026.H11 (5) 026:H11 (2) 
OllliNM (1) OHl:NM (2) 
O103:H2 (1) OHl:H NT* (1) 
O NT:NM (1) 
O NT:H4 (2) 
O7.H40 (1) 
HC 0157:H7 (1) 
O NT:NM (1) 
HUS 026:H11 (1) 
OHl:H8(l) 








NOTE. Levels of cytotoxin were defined by the CDso/ml of bacterial sonic lysate, and the type of cytotoxin was defined as 
follows: I = neutralized by antibody to Shiga toxin and II = not neutralized by antibody to Shiga toxin. 
* HC = hemorrhagic olitis. 
t HUS = hemolytic uremic syndrome. 
t NT = nontypable. 
only one of these strains was isolated from a healthy in- 
dividual (tables 1 and 2). All high-level cytotoxin producers 
had 10-100-fold less CDso/ml of culture supernatant than 
per ml of sonic lysate. Sonic lysate activity of all strains 
was neutralized by antibody to Shiga toxin. Supernatant 
activity of 21 strains was completely neutralized by anti- 
body to Shiga toxin (shown on table 2 as producers of 
one type of cytotoxin), whereas for 18 strains this activ- 
ity was either partially neutralized or not neutralized by 
antibody to Shiga toxin (shown on table 2 as producers 
of two types of cytotoxin). Two EHEC were isolates from 
outbreaks of hemorrhagic colitis, and the isolate from 
food was implicated in one of these outbreaks. Of all the 
strains belonging to EPEC serogroups, high levels of 
cytotoxin(s) were detected only in those belonging to 
serogroups 026 (8 of 12 strains, serotype 026:H11) and 
Olll (5 of 34 strains, serotype OlllrNM; one strain, 
OHl:H8; and one strain, OllLH NT). Two strains of 
EPEC 026 (H30 and HI9) have been reported to pro- 
duce a cytotoxin active on Vero cells [12]. 
Discussion 
All strains of E. coli may make at least small amounts of 
cell-associated cytotoxin, since some strains with no de- 
tectable activity in sonic lysates showed cytotoxicity in ly- 
sates prepared by the French pressure method. However, 
the low-level cytotoxicity of some strains was not neutral- 
ized by antibody to Shiga toxin. Some strains produced 
one type of cytotoxin (moderate- and high-level producers), 
and some strains produced two types of cytotoxin (high- 
level producers). All strains of E. coli 0157:H7 produced 
elevated levels (moderate or high) of cytotoxin(s). 
Cell-associated cytotoxicity not neutrahzable by anti- 
body to Shiga toxin has been reported [2, 4]. Konowal- 
chuk et al. [12] reported that the extracellular cytotoxin 
of one strain of E. coli isolated from an infant with diar- 
rhea (serogroup 0128) and one strain isolated from a suck- 
ling pig with diarrhea (serogroup 0138) was antigenically 
different from the cytotoxin of E. coli strain H30. Smith 
et al. [13] also detected antigenic variants of "Vero 
cytotoxin" produced by strains isolated from pigs, and 
Scotland et al. [14] reported antigenic variation of extracel- 
lular cytotoxin from strains of E. coli 0157. 
Recent studies m our laboratory have shown that EHEC 
strain 933 produces two cytotoxins that are antigenically 
distinct but have the same biologic activities and similar 
genetic determinants as those of Shiga toxin. Antiserum 
to a crude preparation of the antigenic variant of Shiga- 
like toxin neutralized the cytotoxicity of all 10 moderate- 
Table 2. Production of elevated levels of cytotoxin(s) by E. coli 
Cytotoxin 
Level Type of disease Humans Calves Food 
Clinical manifestation Serotypes 
of strains isolated from (no. of strains) 
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level producers, and a mixture of this antiserum and 
antibody to Shiga toxin completely neutralized the super- 
natant activity of the other 17 high-level producers of two 
types of cytotoxin described in the present paper [14a]. 
Studies are in progress to determine whether the non- 
neutralizable cytotoxin produced at low levels is the same 
as or different from the antigenic variant of Shiga-like toxin 
produced by EHEC strain 933. 
Elevated levels of cytotoxin(s) were found almost ex- 
clusively (48 of 49) in strains of E. coli isolated from cases 
of diarrhea, hemorrhagic colitis or hemolytic uremic syn- 
drome, and food implicated in an outbreak of hemorrhagic 
colitis. This finding suggests that cytotoxin(s) produced 
at elevated levels play a role in the pathogenesis of such 
diseases. All strains isolated from patients with hemolytic 
uremic syndrome have previously been described as "Vero 
cytotoxin" producers [15]. Karmali et al. [15] pointed out 
the marked similarities between hemorrhagic colitis and 
the colitis seen early in the hemolytic uremic syndrome 
and suggested that these diseases belong in a spectrum of 
clinical manifestations of the same underlying process. 
Because strains isolated from humans without illness 
made cytotoxin at much lower levels than did some strains 
from sources with disease, cytotoxin may be only a viru- 
lence determinant for E. coli when it is produced in large 
amounts. Small amounts of cytotoxin, however, could 
damage host cells if delivered by strains off. coli that ad- 
here avidly to or that invade intestinal epithelial cells. It 
should also be emphasized that the amount of cytotoxin 
produced in vitro may not correlate with the amount pro- 
duced in vivo. 
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